fda warning about compounded semaglutide The Risks of Products FDA Warns Against Compounded Semaglutide

It significantly impacts quality of life and economic productivity

Retatrutide vs Semaglutide is mainly a comparison between an investigational medicine and approved semaglutide products

For peptides, COAs typically include HPLC purity percentage and mass spectrometry results verifying molecular weight matches the target compound

Common side effects include: Nausea and vomiting Diarrhoea or constipation Reduced appetite Abdominal discomfort or bloating Injection site reactions (redness, itching, or mild swelling) These effects can often be managed by eating smaller, lower-fat meals, avoiding lying down immediately after eating, staying well hydrated, and adhering to the gradual dose-escalation schedule